Keywords: Turkey, Pharma market, Outlook, GMP compliance, BMI

Turkey one of the most promising CEE pharmaceutical markets, but has short-term challenges, says BMI

Article | 12 January 2011

Turkey remains one of the most promising pharmaceutical markets in Central and Eastern Europe (CEE) in the long term. However, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in